New product: Ngenla (somatrogen) 24 mg and 60mg solution for injection in pre-filled pen
Ngenla is licensed for the treatment of children and adolescents from 3 years of age with growth disturbance due to insufficient secretion of growth hormone.
Source:
electronic Medicines compendium
SPS commentary:
SPC for 60mg solution for injection